Toxicity Profile of Solvents by Aspiration Approach for Topical Agent Delivery to Respiratory Tract Epithelium
暂无分享,去创建一个
V. Steele | Sheela Sharma | Jin Lee | P. Gao
[1] C. Spire,et al. Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats. , 2010, Regulatory toxicology and pharmacology : RTP.
[2] S. Croft,et al. In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone , 2010, Drug development and industrial pharmacy.
[3] W. Jia,et al. Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system. , 2010, Chemical & pharmaceutical bulletin.
[4] R. Gannu,et al. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. , 2010, International journal of pharmaceutics.
[5] P. Diot,et al. Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[6] G. P. Martin,et al. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] Reginald G. Hills,et al. The effects of chrysin, a Passiflora incarnata extract, on natural killer cell activity in male Sprague-Dawley rats undergoing abdominal surgery. , 2008, AANA journal.
[8] H. Himmel. Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential. , 2007, Journal of pharmacological and toxicological methods.
[9] M. Winterhalter,et al. Verursacht die Infusion oder Inhalation von Prostaglandin-Trägerlösungen (Äthanol, Glycin-Puffer) pulmonalvaskuläre oder respiratorische Effekte? , 2007 .
[10] Akira Yamamoto,et al. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. , 2007, Biological & pharmaceutical bulletin.
[11] R. Guy,et al. Formulation and evaluation of a testosterone transdermal spray. , 2006, Journal of pharmaceutical sciences.
[12] J. Chung,et al. Effects of dimethylsulfoxide on metabolism and toxicity of acetaminophen in mice. , 2006, Biological & pharmaceutical bulletin.
[13] C. Sabourin,et al. Evaluation of Acute Immunotoxicity of Aerosolized Aflatoxin B1 in Female C57BL/6N Mice , 2006, Journal of immunotoxicology.
[14] V. Steele,et al. The chemopreventive efficacy of inhaled oltipraz particulates in the B[a]P-induced A/J mouse lung adenoma model. , 2005, Carcinogenesis.
[15] S. Venkatesh,et al. Aqueous and cosolvent solubility data for drug-like organic compounds , 2005, The AAPS Journal.
[16] Robin D. Rogers,et al. Polyethylene glycol and solutions of polyethylene glycol as green reaction media , 2005 .
[17] R. Gurny,et al. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. , 2004, International journal of pharmaceutics.
[18] H. Saitoh,et al. β-Cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs , 2004 .
[19] Georges Houin,et al. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. , 2004, International journal of pharmaceutics.
[20] K. Donaldson,et al. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types , 2004, Occupational and Environmental Medicine.
[21] C. McKerlie,et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Venkatareddy Nadithe,et al. Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs. , 2003, Journal of pharmaceutical sciences.
[23] Kanji Takada,et al. Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats. , 2003, International journal of pharmaceutics.
[24] Mark D. Hoover,et al. Efficacy of a Technique for Exposing the Mouse Lung to Particles Aspirated from the Pharynx , 2003, Journal of toxicology and environmental health. Part A.
[25] N. Shibata,et al. Absorption Enhancing Effect of Labrasol on the Intestinal Absorption of Insulin in Rats , 2002, Journal of drug targeting.
[26] N. Shibata,et al. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. , 2001, Life sciences.
[27] T. Fujita,et al. Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside , 1999, The Journal of pharmacy and pharmacology.
[28] N. Hara,et al. The effects of a specific tachykinin receptor antagonist FK‐224 on ozone‐induced airway hyperresponsiveness and inflammation , 1997, Respirology.
[29] J. Beijnen,et al. Alternative formulations of paclitaxel. , 1997, Cancer treatment reviews.
[30] J. Widdicombe,et al. Actions of moguisteine on cough and pulmonary rapidly adapting receptor activity in the guinea pig. , 1997, Pharmacological research.
[31] T. Fujita,et al. Effectiveness and Toxicity Screening of Various Absorption Enhancers in the Rat Small Intestine: Effects of Absorption Enhancers on the Intestinal Absorption of Phenol Red and the Release of Protein and Phospholipids from the Intestinal Membrane , 1996, The Journal of pharmacy and pharmacology.
[32] B. Fröseth,et al. Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values. , 1995, Respiratory medicine.
[33] C. Andresen,et al. Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. , 1994, American journal of respiratory and critical care medicine.
[34] W. Clark,et al. High alveolar surface tension increases clearance of technetium 99m diethylenetriamine-pentaacetic acid. , 1990, The Journal of thoracic and cardiovascular surgery.
[35] J. Kosek,et al. Carcinogen Bioassay of Isoflurane in Mice , 1988, Anesthesiology.
[36] K. Gossett. Variation of Differential Cell Counts of Bronchoalveolar Lavage Fluid , 1987 .
[37] S. Wickramasinghe,et al. Haematological abnormalities in mice continuously exposed to ethanol vapour. , 1986, British journal of experimental pathology.
[38] J. M. Baden,et al. Effects of subchronic intermittent exposure to isoflurane in Swiss Webster mice. , 1986, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[39] W. W. Davis,et al. Normal and promoted gastrointestinal absorption of water-soluble substances. I. Induced rapidly reversible hyperabsorptive state in the canine fundic stomach pouch. , 1970, Journal of pharmaceutical sciences.
[40] M. Mena,et al. Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[41] M. Winterhalter,et al. [Are there pulmonary vascular or respiratory effects of prostaglandin vehicles (ethanol, glycine buffer) after intravenous infusion or inhalation?]. , 2007, Pneumologie.
[42] H. Saitoh,et al. Beta-cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.
[43] D. Dodd,et al. Two-week aerosol inhalation study on polyethylene glycol (PEG) 3350 in F-344 rats. , 1989, Drug and chemical toxicology.
[44] N. A. David. The pharmacology of dimethyl sulfoxide. , 1972, Annual Review of Pharmacology.